Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED) (P3-9.001) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Moster, Mark
  • Douglas, Raymond
  • Cockerham, Kimberly
  • Turbin, Roger
  • Nijhawan, Navdeep
  • Schiffman, Jade
  • Ugradar, Shoaib
  • O’Shaughnessy, Denis
  • Summerfelt, Rochelle
  • She, Angela
  • Katz, Barrett

publication date

  • April 25, 2023